P1286: MIXED CHIMAERISM IS ASSOCIATED WITH POORER LONG-TERM FAILURE-FREE SURVIVAL AMONG APLASTIC ANAEMIA PATIENTS RECEIVING HLA-MATCHED DONOR TRANSPLANTATION

P1286: MIXED CHIMAERISM IS ASSOCIATED WITH POORER LONG-TERM FAILURE-FREE SURVIVAL AMONG APLASTIC ANAEMIA PATIENTS RECEIVING HLA-MATCHED DONOR TRANSPLANTATION

Bibliographic Details
Main Authors:	Zhengli Xu, Lanping Xu, Xiaojun Huang
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000972032.85708.6e

Similar Items

Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors.
by: Hamblin, M, et al.
Published: (1996)

Long-term outcome after marrow transplantation from HLA-identical sibling donors for acquired aplastic anaemia using cyclophosphamide and in-vivo anti-CD52 monoclonal antibodies
by: Gupta, V, et al.
Published: (2005)

Successful pregnancy following aplastic anaemia.
by: Leong, K.W., et al.
Published: (1995)

The Benign Clone Causing Aplastic Anaemia
by: Shaun R. McCann, et al.
Published: (2023-06-01)

Favourable impact on acute and chronic graft-versus-host disease with cyclophosphamide and in-vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anaemia.
by: Gupta, V, et al.
Published: (2004)

The effect of HLA matching and donor relatedness on the risk of autoimmune haemolytic anaemia in haematopoietic stem cell transplant recipients: A systematic review and meta‐analysis
by: Cassandra Kennedy, et al.
Published: (2022-08-01)

Mapping aplastic anaemia hospital activity in England
by: Bamidele Famokunwa, et al.
Published: (2024-04-01)

The outcome of aplastic anaemia associated with terbinafine therapy
by: Farhan Khalid, et al.
Published: (2023-12-01)

Acquired Amegakaryocytic Thrombocytopenia Progressingto Aplastic Anaemia
by: Syed Ather Hussain, et al.
Published: (2022-09-01)

The impact of recipient HLA-Cw and donor killer immunoglobulin-like receptor genotyping on the outcome of patients receiving HLA-matched sibling donor haematopoietic stem cell transplantation for myeloid malignancies
by: Hua Wang, et al.
Published: (2012-12-01)

Intra‐arterial transplantation of HLA‐matched donor mesoangioblasts in Duchenne muscular dystrophy
by: Giulio Cossu, et al.
Published: (2016-12-01)

The HLA System: An Update and Relevance to Patient-Donor Matching Strategies in Clinical Transplantation
by: Preeyanat Vongchan
Published: (2015-02-01)

Impacts on Donor-Recipient HLA Matching on Operational Tolerance Following Pediatric Living-Donor Liver Transplantation
by: Ohe, H, et al.
Published: (2011)

Clinical and hematological profile of patients with severe aplastic anaemia
by: E A Ashok Kumar, et al.
Published: (2015-01-01)

Pollen coatings - chimaeric genetics and new functions
by: Dickinson, H, et al.
Published: (2000)

PTCY-Based Haploidentical Donor Transplantation versus HLA-Matched Related and Unrelated Donor Transplantations in Patients with Refractory or Relapsed Lymphoma—A Matched-Pair Analysis
by: Sarah Haebe, et al.
Published: (2023-10-01)

P1317: TIME-DEPENDENT ANALYSIS OF THE IMPACT ON EARLY CMV REACTIVATION OF HLA MISMATCH AND ACUTE GRAFT-VERSUS-HOST-DISEASE AFTER ALLO-HSCT FROM RELATED DONORS IN ACQUIRED APLASTIC ANEMIA.
by: Fan Lin, et al.
Published: (2023-08-01)

Successful Hematopoietic Stem Cell Transplantation from a Matched Related Donor with Beta-Thalassemia Minor for Severe Aplastic Anemia
by: Mi Young Jung, et al.
Published: (2020-10-01)

Familial immune‐mediated aplastic anaemia in six different families
by: Tatsuya Imi, et al.
Published: (2023-08-01)

COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR
by: Selim SAYIN
Published: (2024-02-01)

The Incidence, Outcomes, and Risk Factors of Secondary Poor Graft Function in Haploidentical Hematopoietic Stem Cell Transplantation for Acquired Aplastic Anemia
by: Fan Lin, et al.
Published: (2022-05-01)

Exploring strategies to optimise outcomes in hepatitis-associated aplastic anaemia patients following haematopoietic stem cell transplantation
by: Jia Li, et al.
Published: (2024-03-01)

Comparison of Conventional Cyclophosphamide versus Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched-Related Donor Transplantation
by: Raheel Iftikhar, et al.
Published: (2020-05-01)

Aplastic anaemia associated with bendamustine therapy – a rare side effect
by: Salman Khan, et al.
Published: (2024-02-01)

Application prospect of low-dose porcine anti-thymocyte globulin in HLA-matched sibling donor transplantation
by: Xin Chen, et al.
Published: (2023-12-01)

A case of strongyloidiasis with aplastic anaemia: A common disease with an uncommon presentation
by: Alka Singh, et al.
Published: (2023-01-01)

Outcomes of hepatitis associated aplastic anaemia (HAAA): A single centre study
by: Rishab Bharadwaj, et al.
Published: (2022-01-01)

The role of donor-specific HLA alloantibodies in liver transplantation.
by: O'Leary, J, et al.
Published: (2014)

PB2188: APPLICATION PROSPECT OF LOW DOSE PORCINE ANTITHYMOCYTE GLOBULIN IN HLA MATCHED SIBLING DONOR TRANSPLANTATION
by: X. chen, et al.
Published: (2022-06-01)

Analysis of the results of allogeneic hematopoietic stem cell transplantation depending on HLA matching of the unrelated donor / recipient pair
by: Ye. V. Kuzmich, et al.
Published: (2015-01-01)

Analysis of the results of allogeneic hematopoietic stem cell transplantation depending on HLA matching of the unrelated donor / recipient pair
by: Ye. V. Kuzmich, et al.
Published: (2015-01-01)

Haploidentical donor stem cell transplantation had a lower incidence of bronchiolitis obliterans syndrome compared with HLA-matched sibling donor transplantation in patients with hematologic malignancies: Benefit from ATG?
by: Guangyang Weng, et al.
Published: (2022-10-01)

Transplantation of the bone marrow from a HLA-compatible unrelated donor after immunoablative conditioning in children with acquired aplastic anemia unresponsive to combined immunosuppressive therapy: Preliminary results
by: G A Novichkova, et al.
Published: (2010-07-01)

HLA-B Matching Prolongs Allograft Survival in Islet Cell Transplantation
by: Joana R. N. Lemos, et al.
Published: (2023-08-01)

HLA-DR-matched Parental Donors for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with High-risk Acute Leukemia
by: Shang-Ju Wu, et al.
Published: (2009-05-01)

Comparison of clinical features of nephrotic syndrome after haploidentical and matched donor hematopoietic stem cell transplantation
by: Wei Sun, et al.
Published: (2024-02-01)

Novel HIV-1 clade B candidate vaccines designed for HLA-B*5101(+) patients protected mice against chimaeric ecotropic HIV-1 challenge.
by: Roshorm, Y, et al.
Published: (2009)

P1310: HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HEPATITIS‑ASSOCIATED APLASTIC ANEMIA AND NON‑HEPATITIS‑ASSOCIATED APLASTIC ANEMIA: A PROPENSITY SCORE-MATCHED ANALYSIS
by: Jia LI
Published: (2023-08-01)

Eltrombopag with or without Tacrolimus for relapsed/refractory acquired aplastic anaemia: a prospective randomized trial
by: Jiang Ji, et al.
Published: (2023-09-01)

Immune checkpoint inhibitor-induced aplastic anaemia: Case series and large-scale pharmacovigilance analysis
by: Qian Guo, et al.
Published: (2023-01-01)